Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Strategic Education, Inc. | 12 | 0 | 0 | 0 | €109.00 | €120.00 | 10.092% |
| Avadel Pharmaceuticals plc ADR | 17 | 0 | 16 | 0 | €15.10 | €18.00 | 19.205% |
| Hikari Tsushin Inc. | 1 | 0 | 0 | 0 | €175.00 | €200.00 | 14.286% |
| IAMGOLD Corp. | 8 | 1 | 1 | 0 | €3.74 | €4.61 | 23.043% |
| Ani Pharmaceuticals Inc. | 18 | 1 | 18 | 1 | €58.00 | €69.75 | 20.259% |
| Cerus Corp. | 4 | 0 | 0 | 0 | €2.16 | €3.26 | 50.476% |
| Nice Systems Ltd ADR | 32 | 0 | 1 | 0 | €164.00 | €253.67 | 54.678% |
| Penn National Gaming | 17 | 0 | 2 | 0 | €18.18 | €26.71 | 46.946% |
| Novartis AG ADR | 21 | 1 | 19 | 1 | €99.00 | €110.00 | 11.111% |
| Verint Systems Inc | 16 | 0 | 0 | 0 | €30.60 | €36.74 | 20.065% |
| Seabridge G. | 1 | 0 | 0 | 0 | €13.63 | - | - |
| Scansource Inc. | 2 | 0 | 0 | 0 | €40.60 | - | - |
| JPMorgan Chase & Co. | 51 | 2 | 20 | 2 | €193.80 | €203.92 | 5.220% |
| Genmab A/S | 19 | 0 | 19 | 0 | €249.50 | €275.00 | 10.220% |
| Sarepta Therapeutics | 20 | 0 | 19 | 0 | €131.95 | €180.00 | 36.415% |
| Acadia Pharmaceuticals | 29 | 1 | 3 | 0 | €16.51 | €31.28 | 89.523% |
| Fluor Corp. | 6 | 0 | 1 | 0 | €44.06 | €43.10 | -2.187% |
| TechnipFMC PLC | 18 | 0 | 1 | 0 | €25.36 | €27.93 | 10.134% |
| Iron Mountain | 8 | 1 | 2 | 0 | €89.80 | €89.06 | -0.820% |
| SYZYGY AG | 1 | 0 | 0 | 0 | €3.48 | - | - |
| Takkt AG | 6 | 2 | 5 | 2 | €11.60 | €13.50 | 16.379% |
| Brunswick Corp. | 20 | 0 | 4 | 0 | €74.74 | €89.50 | 19.751% |
| CMS Energy Corp. | 13 | 1 | 0 | 0 | €57.00 | €59.36 | 4.148% |
| SPX Technologies Inc. | 5 | 0 | 0 | 0 | €133.00 | - | - |
| Harmony Gold Mining | 14 | 1 | 12 | 0 | €9.18 | €10.50 | 14.379% |